Bioactive natural products from novel microbial sources

Annals of the New York Academy of Sciences

Volumn 1354, Issue 1, 2015, Pages 82-97

  Challinor, Victoria L ^a   Bode, Helge B ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Natural products; Photorhabdus; Secondary metabolites; Symbiotic bacteria; Xenorhabdus

Indexed keywords

ANTHRAQUINONE DERIVATIVE; ANTIBIOTIC AGENT; ARIMETAMYCIN A; BACTERIOCIN; BIOACTIVE NATURAL PRODUCT; BURKHOLDERIC ACID; CALIXANTHOMYCIN; CETONIACYTONE A; DIALKYL RESORCINOL DERIVATIVE; GLIDOBACTIN A; GRAMICIDIN; HYDROXYSTILBENE DERIVATIVE; INDOLE; JAGARICIN; JANTHINOCIN A; LACTOCILLIN; LANTIBIOTIC; LFF 571; MALLEIPEPTIN A; MALLEOBACTIN A; NATURAL PRODUCT; PEPTIDE; PRODRUG; PYRROTHINE; REDUCTASPORINE; RESORCINOL DERIVATIVE; STILBENE DERIVATIVE; TEIXOBACTIN; THAILANDAMIDE A; UNCLASSIFIED DRUG; UNINDEXED DRUG; ANTIINFECTIVE AGENT; BIOLOGICAL PRODUCT;

ANAEROBE; ARTICLE; BACTERIAL STRAIN; BACTERIUM; BURKHOLDERIALES; FUNGUS; HUMAN; HYBRID; INSECT; MICROBIOME; MICROORGANISM; NEMATODE; NONHUMAN; SYMBIONT; ANIMAL; ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; CLASSIFICATION; DRUG EFFECTS; METABOLISM; MICROBIOLOGY; SYMBIOSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; BIOLOGICAL PRODUCTS; DRUG RESISTANCE, MICROBIAL; HUMANS; INSECTS; NEMATODA; SYMBIOSIS;

EID: 84945249205     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12954     Document Type: Article

References (130)

1. Hampton, T. 2013. Report reveals scope of US antibiotic resistance threat. JAMA 310: 1661-1663.
2. United States Department of Health and Human Services Centers for Disease Control and Prevention 2013. Antibiotic resistance threats in the United States, 2013. Accessed July 24, 2015. http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf.
3. Davies, S.C. et al. 2013. Annual report of the chief medical officer: infections and the rise of antimicrobial resistance. Lancet 381: 1606-1609.
4. Blair, J.M.A. et al. 2014. Molecular mechanisms of antibiotic resistance. Nat. Rev. Microbiol. 13: 42-51.
5. Genilloud, O. 2014. The re-emerging role of microbial natural products in antibiotic discovery. Antonie van Leeuwenhoek 106: 173-188.
6. Koehn, F.E. & G.T. Carter . 2005. The evolving role of natural products in drug discovery. Nat. Rev. Drug Discov. 4: 206-220.
7. Cragg, G.M. & D.J. Newman . 2013. Natural products: a continuing source of novel drug leads. Biochim. Biophys. Acta 1830: 3670-3695.
8. Newman, D.J. & G.M. Cragg . 2012. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 75: 311-335.
9. Watve, M. et al. 2001. How many antibiotics are produced by the genus Streptomyces? Arch. Microbiol. 176: 386-390.
10. Piel, J. 2011. Approaches to capturing and designing biologically active small molecules produced by uncultured microbes. Annu. Rev. Microbiol. 65: 431-453.
11. Baltz, R.H. 2007. Antimicrobials from actinomycetes: back to the future. Microbe 2: 125-131.
12. Marahiel, M.A. 1992. Molekularbiologie und regulationsmechanismen der antibiotikaproduktion. Naturwissenschaften 79: 202-212.
13. Mannanov, R.N. & R.K. Sattarova . 2001. Antibiotics produced by Bacillus bacteria. Chem. Nat. Compd. 37: 117-123.
14. Hamdache, A. et al. 2011. Non-peptide metabolites from the genus Bacillus. J. Nat. Prod. 74: 893-899.
15. Fickers, P. 2012. Antibiotic compounds from Bacillus: why are they so amazing? Am. J. Biochem. Biotechnol. 8: 38-43.
16. Reichenbach, H. et al. 1988. Myxobacteria: a source of new antibiotics. Trends Biotechnol. 6: 115-121.
17. Reichenbach, H. 2001. Myxobacteria, producers of novel bioactive substances. J. Ind. Microbiol. Biotechnol. 27: 149-156.
18. Weissman, K.J. & R. Müller . 2010. Myxobacterial secondary metabolites: bioactivities and modes-of-action. Nat. Prod. Rep. 27: 1276-1220.
19. Schäberle, T.F. et al. 2014. Antibiotics from myxobacteria. Nat. Prod. Rep. 31: 953-920.
20. Garcia, R.O., D. Krug & R. Müller . 2009. Discovering natural products from myxobacteria with emphasis on rare producer strains in combination with improved analytical methods. Methods Enzymol. 458: 59-91.
21. Ringel, S.M., R.C. Greenough & S. Roemer . 1977. Ambruticin (W7783), a new antifungal antibiotic. J. Antibiot. 30: 371-375.
22. Williams, D.R., J.J. Li & R.H. Hutchings . 2000. An overview of synthetic studies of antibiotics from myxobacteria. Org. Prep. Proced. Int. 32: 409-451.
23. Schiess, R. & K.-H. Altmann . 2015. "Epothilones." In RSC Drug Discovery Series 40 (Macrocycles in Drug Discovery). J. Levin, Ed.: 78-108. Cambridge: Royal Society of Chemistry.
24. Torsvik, V., J. Goksøyr & F.L. Daae . 1990. High diversity in DNA of soil bacteria. Appl. Environ. Microbiol. 56: 782-787.
25. Gutell, R.R., N. Larsen & C.R. Woese . 1994. Lessons from an evolving rRNA: 16S and 23S rRNA structures from a comparative perspective. Microbiol. Rev. 58: 10-26.
26. Amann, R.I., W. Ludwig & K.H. Schleifer . 1995. Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbiol. Rev. 59: 143-169.
27. Bode, H.B. et al. 2002. Big effects from small changes: possible ways to explore nature's chemical diversity. ChemBioChem 3: 619-627.
28. Netzker, T. et al. 2015. Microbial communication leading to the activation of silent fungal secondary metabolite gene clusters. Front. Microbiol. 6: 299.
29. Kaeberlein, T., K. Lewis & S.S. Epstein . 2002. Isolating 'uncultivable' microorganisms in pure culture in a simulated natural environment. Science 296: 1127-1129.
30. Ling, L.L. et al. 2015. A new antibiotic kills pathogens without detectable resistance. Nature 517: 455-459.
31. Nichols, D. et al. 2010. Use of ichip for high-throughput in situ cultivation of 'uncultivable' microbial species. Appl. Environ. Microbiol. 76: 2445-2450.
32. Lincke, T. et al. 2010. Closthioamide: an unprecedented polythioamide antibiotic from the strictly anaerobic bacterium Clostridium cellulolyticum. Angew. Chem. Int. Ed. 49: 2011-2013.
33. Rutledge, P.J. & G.L. Challis . 2015. Discovery of microbial natural products by activation of silent biosynthetic gene clusters. Nat. Rev. Microbiol. 13: 509-523.
34. Owen, J.G. et al. 2013. Mapping gene clusters within arrayed metagenomic libraries to expand the structural diversity of biomedically relevant natural products. Proc. Natl. Acad. Sci. U. S. A. 110: 11797-11802.
35. Milshteyn, A., J.S. Schneider & S.F. Brady . 2014. Mining the metabiome: identifying novel natural products from microbial communities. Chem. Biol. 21: 1211-1223.
36. Chang, F.-Y. et al. 2015. Targeted metagenomics: finding rare tryptophan dimer natural products in the environment. J. Am. Chem. Soc. 137: 6044-6052.
37. Kang, H.-S. & S.F. Brady . 2014. Mining soil metagenomes to better understand the evolution of natural product structural diversity: pentangular polyphenols as a case study. J. Am. Chem. Soc. 136: 18111-18119.
38. Kang, H.-S. & S.F. Brady . 2013. Arimetamycin A: improving clinically relevant families of natural products through sequence-guided screening of soil metagenomes. Angew. Chem. Int. Ed. 52: 11063-11067.
39. Sturgen, N.O. & L.E. Casida, Jr. 1962. Antibiotic production by anaerobic bacteria. Appl. Environ. Microbiol. 10: 55-59.
40. Kloss, F., T. Lincke & C. Hertweck . 2011. Highly efficient total synthesis of the Clostridium-derived anti-MRSA antibiotic closthioamide. Eur. J. Org. Chem. 2011: 1429-1431.
41. Behnken, S. & C. Hertweck . 2012. Anaerobic bacteria as producers of antibiotics. Appl. Environ. Microbiol. 96: 61-67.
42. Letzel, A.-C., S.J. Pidot & C. Hertweck . 2013. A genomic approach to the cryptic secondary metabolome of the anaerobic world. Nat. Prod. Rep. 30: 392-428.
43. Rose, H. et al. 2009. Biocide susceptibility of the Burkholderia cepacia complex. J. Antimicrob. Chemother. 63: 502-510.
44. Watanabe, T., T. Suzuki & K. Izaki . 1991. New polyenic antibiotics active against Gram-positive and Gram-negative bacteria. V. Mode of action of enacyloxin IIa. J. Antibiot. 44: 1457-1459.
45. Mahenthiralingam, E. et al. 2011. Enacyloxins are products of an unusual hybrid modular polyketide synthase encoded by a cryptic Burkholderia ambifaria genomic island. Chem. Biol. 18: 665-677.
46. Franke, J. et al. 2013. Nitro versus hydroxamate in siderophores of pathogenic bacteria: effect of missing hydroxylamine protection in malleobactin biosynthesis. Angew. Chem. Int. Ed. Engl. 52: 8271-8275.
47. Franke, J., K. Ishida & C. Hertweck . 2012. Genomics-driven discovery of burkholderic acid, a noncanonical, cryptic polyketide from human pathogenic Burkholderia species. Angew. Chem. Int. Ed. Engl. 51: 11611-11615.
48. Biggins, J.B. et al. 2014. The chemical arsenal of Burkholderia pseudomalleiIs essential for pathogenicity. J. Am. Chem. Soc. 136: 9484-9490.
49. Nguyen, T. et al. 2008. Exploiting the mosaic structure of trans-acyltransferase polyketide synthases for natural product discovery and pathway dissection. Nat. Biotechnol. 26: 225-233.
50. Oka, M. et al. 1988. Glidobactins A, B and C, new antitumor antibiotics. II. Structure elucidation. J. Antibiot. 41: 1338-1350.
51. Johnson, J.H., A.A. Tymiak & M.S. Bolgar . 1990. Janthinocins A, B and C, novel peptide lactone antibiotics produced by Janthinobacterium lividum. II. Structure elucidation. J. Antibiot. 43: 920-930.
52. Graupner, K. et al. 2012. Imaging mass spectrometry and genome mining reveal highly antifungal virulence factor of mushroom soft rot pathogen. Angew. Chem. Int. Ed. 51: 13173-13177.
53. Crawford, J.M. & J. Clardy . 2011. Bacterial symbionts and natural products. Chem. Commun. 47: 7559-7566.
54. Piel, J.R. 2004. Metabolites from symbiotic bacteria. Nat. Prod. Rep. 21: 519-520.
55. Piel, J.R. 2009. Metabolites from symbiotic bacteria. Nat. Prod. Rep. 26: 338-362.
56. LaMarche, M.J. et al. 2012. Discovery of LFF571: an investigational agent for Clostridium difficile infection. J. Med. Chem. 55: 2376-2387.
57. Schneditz, G. et al. 2014. Enterotoxicity of a nonribosomal peptide causes antibiotic-associated colitis. Proc. Natl. Acad. Sci. U. S. A. 111: 13181-13186.
58. Nougayrède, J.P. et al. 2006. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 313: 848-851.
59. Bode, H.B. 2015. The microbes inside us and the race for colibactin. Angew. Chem. Int. Ed. Engl. 54: 10408-10411.
60. Gebhardt, K. et al. 2002. Endophenazines A-D, new phenazine antibiotics from the arthropod associated endosymbiont Streptomyces anulatus. I. Taxonomy, fermentation, isolation and biological activities. J. Antibiot. 55: 794-800.
61. Gebhardt, K. et al. 2002. Screening for biologically active metabolites with endosymbiotic bacilli isolated from arthropods. FEMS Microbiol. Lett. 217: 199-205.
62. Schlörke, O. et al. 2002. Structure and biosynthesis of cetoniacytone A, a cytotoxic aminocarba sugar produced by an endosymbiontic Actinomyces. J. Antibiot. 55: 635-642.
63. Ramadhar, T.R. et al. 2014. Bacterial symbionts in agricultural systems provide a strategic source for antibiotic discovery. J. Antibiot. (Tokyo) 67: 53-58.
64. Oh, D.-C. et al. 2009. Dentigerumycin: a bacterial mediator of an ant-fungus symbiosis. Nat. Chem. Biol. 5: 391-393.
65. Carr, G. et al. 2012. Antibiotic and antimalarial quinones from fungus-growing ant-associated Pseudonocardia sp. J. Nat. Prod. 75: 1806-1809.
66. Oh, D.-C. et al. 2009. Mycangimycin, a polyene peroxide from a mutualist Streptomyces sp. Org. Lett. 11: 633-636.
67. Herbert, E.E. & H. Goodrich-Blair . 2007. Friend and foe: the two faces of Xenorhabdus nematophila. Nat. Rev. Microbiol. 5: 634-646.
68. Dutky, S.R. 1959. Insect microbiology. Adv. Appl. Microbiol. 1: 175-200.
69. Poinar Jr., G.O., R. Hess & G. Thomas . 1980. Isolation of defective bacteriophages from Xenorhabdus spp. (Enterobacteriaceae). IRCS Med. Sci. 8: 141.
70. Li, J., K. Hu & J.M. Webster . 1998. Antibiotics from Xenorhabdus spp. and Photorhabdus spp. (Enterobacteriaceae). Chem. Heterocyc. Compd. 34: 1331-1339.
71. Kennedy, G. et al. 2000. Studies on the novel anti-staphyloccal compound nematophin. Bioorg. Med. Chem. Lett. 10: 1751-1754.
72. Chaston, J.M. et al. 2011. The entomopathogenic bacterial endosymbionts Xenorhabdus and Photorhabdus: convergent lifestyles from divergent genomes. PLoS One 6: e27909.
73. Bode, H.B. et al. 2012. Determination of the absolute configuration of peptide natural products by using stable isotope labeling and mass spectrometry. Chem. Eur. J. 18: 2342-2348.
74. Nollmann, F.I. et al. 2014. Insect-specific production of new GameXPeptides in Photorhabdus luminescens TTO1, widespread natural products in entomopathogenic bacteria. ChemBioChem 16: 205-208.
75. Lang, G. et al. 2008. Linear and cyclic peptides from the entomopathogenic bacterium Xenorhabdus nematophilus. J. Nat. Prod. 71: 1074-1077.
76. Crawford, J.M. et al. 2011. NRPS substrate promiscuity diversifies the xenematides. Org. Lett. 13: 5144-5147.
77. Hung, K.-Y. et al. 2011. A. synthesis and assignment of stereochemistry of the antibacterial cyclic peptide xenematide. Org. Biomol. Chem. 9: 236-242.
78. Ohlendorf, B. et al. 2011. Szentiamide, an N-formylated cyclic depsipeptide from Xenorhabdus szentirmaii DSM 16338T. Nat. Prod. Commun. 6: 1247-1250.
79. Nollmann, F.I. et al. 2012. Synthesis of szentiamide, a depsipeptide from entomopathogenic Xenorhabdus szentirmaii with activity against Plasmodium falciparum. Beilstein J. Org. Chem. 8: 528-533.
80. Grundmann, F. et al. 2013. Structure determination of the bioactive depsipeptide xenobactin from Xenorhabdus sp. PB30.3. RSC Adv. 3: 22072-22076.
81. Zhou, Q. et al. 2012. Xentrivalpeptides A-Q: depsipeptide diversification in Xenorhabdus. J. Nat. Prod. 75: 1717-1722.
82. Zhou, Q. et al. 2013. Structure and biosynthesis of xenoamicins from entomopathogenic Xenorhabdus. Chem. Eur. J. 19: 16772-16779.
83. Bode, E. et al. 2015. Simple 'on-demand' production of bioactive natural products. ChemBioChem 16: 1115-1119.
84. Gualtieri, M., A.E. Aumelas & J.-O. Thaler . 2009. Identification of a new antimicrobial lysine-rich cyclolipopeptide family from Xenorhabdus nematophila. 62: 295-302.
85. Fuchs, S.W. et al. 2011. Structure elucidation and biosynthesis of lysine-rich cyclic peptides in Xenorhabdus nematophila. Org. Biomol. Chem. 9: 3130-3133.
86. Reimer, D. et al. 2013. Rhabdopeptides as insect-specific virulence factors from entomopathogenic bacteria. ChemBioChem 14: 1991-1997.
87. Reimer, D. et al. 2014. Xenortide biosynthesis by entomopathogenic Xenorhabdus nematophila. J. Nat. Prod. 77: 1976-1980.
88. Böszörményi, E. et al. 2009. Isolation and activity of Xenorhabdus antimicrobial compounds against the plant pathogens Erwinia amylovora and Phytophthora nicotianae. J. Appl. Microbiol. 107: 746-759.
89. Bode, H.B. et al., inventors. 2014. Novel anti-parasitic peptides from entomopathogenic bacteria. UK Patent GB 2505448, S1A.
90. Derzelle, S. et al. 2002. Identification, characterization, and regulation of a cluster of genes involved in carbapenem biosynthesis in Photorhabdus luminescens. Appl. Environ. Microbiol. 68: 3780-3789.
91. Qin, Z. et al. 2013. Dithiolopyrrolone natural products: isolation, synthesis and biosynthesis. Mar. Drugs 11: 3970-3997.
92. Ettlinger, L. et al. 1959. Stoffwechselprodukte von Actinomyceten 17. MitteilungHolomycin. Helv. Chim. Acta 42: 563-569.
93. Celmer, W.D. & I.A. Solomons . 1955. The structures of thiolutin and aureothricin, antibiotics containing a unique pyrrolinonodithiole nucleus. J. Am. Chem. Soc. 77: 2861-2865.
94. McInerney, B.V. et al. 1991. Biologically active metabolites from Xenorhabdus spp., part 1. Dithiolopyrrolone derivatives with antibiotic activity. J. Nat. Prod. 54: 774-784.
95. Li, J. et al. 1995. Antimicrobial metabolites from a bacterial symbiont. J. Nat. Prod. 58: 1081-1086.
96. Webster, J.M., J. Li & G. Chen, inventors. 1996. Xenorxides with antibacterial and antimycotic properties. Patent number WO1996032396 A1.
97. Li, B. et al. 2014. Dithiolopyrrolones: biosynthesis, synthesis, and activity of a unique class of disulfide-containing antibiotics. Nat. Prod. Rep. 31: 905-923.
98. Hjelmgaard, T., M. Givskov & J. Nielsen . 2007. Expedient total synthesis of pyrrothine natural products and analogs. Org. Biomol. Chem. 5: 344-348.
99. McInerney, B.V. et al. 1991. Biologically active metabolites from Xenorhabdus spp., Part 2. Benzopyran-1-one derivatives with gastroprotective activity. J. Nat. Prod. 54: 785-795.
100. Reimer, D. et al. 2009. A new type of pyrrolidine biosynthesis is involved in the late steps of xenocoumacin production in Xenorhabdus nematophila. ChemBioChem 10: 1997-2001.
101. Park, D. et al. 2009. Genetic analysis of xenocoumacin antibiotic production in the mutualistic bacterium Xenorhabdus nematophila. Mol. Microbiol. 73: 938-949.
102. Reimer, D. et al. 2011. A natural prodrug activation mechanism in nonribosomal peptide synthesis. Nat. Chem. Biol. 7: 888-890.
103. Fuchs, S.W. et al. 2014. Fabclavines: bioactive peptide-polyketide-polyamino hybrids from Xenorhabdus. ChemBioChem 15: 512-516.
104. Masschelein, J. et al. 2015. A combination of polyunsaturated fatty acid, nonribosomal peptide and polyketide biosynthetic machinery is used to assemble the zeamine antibiotics. Chem. Sci. 6: 923-929.
105. Masschelein, J. et al. 2013. A PKS/NRPS/FAS hybrid gene cluster from Serratia plymuthica RVH1 encoding the biosynthesis of three broad spectrum, zeamine-related antibiotics. PLoS One 8: e54143.
106. Richardson, W.H., T.M. Schmidt & K.H. Nealson . 1988. Identification of an anthraquinone pigment and a hydroxystilbene antibiotic from Xenorhabdus luminescens. Appl. Environ. Microbiol. 54: 1602-1605.
107. Li, J. et al. 1995. Identification of two pigments and a hydroxystilbene antibiotic from Photorhabdus luminescens. Appl. Environ. Microbiol. 61: 4329-4333.
108. Hu, K. et al. 1998. Comparison of metabolites produced in vitro and in vivo by Photorhabdus luminescens, a bacterial symbiont of the entomopathogenic nematode Heterorhabditis megidis. Can. J. Microbiol. 44: 1072-1077.
109. Brachmann, A.O. et al. 2007. A type II polyketide synthase is responsible for anthraquinone biosynthesis in Photorhabdus luminescens. ChemBioChem 8: 1721-1728.
110. Paul, V.J. et al. 1981. Antibiotics in microbial ecology: isolation and structure assignment of several new antibacterial compounds from the insect-symbiotic bacteria Xenorhabdus spp. J. Chem. Ecol. 7: 589-597.
111. Sundar, L. & F.N. Chang . 1993. Antimicrobial activity and biosynthesis of indole antibiotics produced by Xenorhabdus nematophilus. J. Gen. Microbiol. 139: 3139-3148.
112. Proschak, A. et al. 2014. Biosynthesis of the insecticidal xenocyloins in Xenorhabdus bovienii. ChemBioChem 15: 369-372.
113. Li, J., G. Chen & J.M. Webster . 1997. Nematophin, a novel antimicrobial substance produced by Xenorhabdus nematophilus (Enterobactereaceae). Can. J. Microbiol. 43: 770-773.
114. Li, J., G. Chen & J.M. Webster . 1997. Synthesis and antistaphylococcal activity of nematophin and its analogs. Bioorg. Med. Chem. 7: 1349-1352.
115. Himmler, T., F. Pirro & N. Schmeer . 1998. Synthesis and antibacterial in vitro activity of novel analogues of nematophin. Bioorg. Med. Chem. Lett. 8: 2045-2050.
116. Proschak, A. et al. 2011. Cytotoxic fatty acid amides from Xenorhabdus. ChemBioChem 12: 2011-2015.
117. Crawford, J.M., R. Kontnik & J. Clardy . 2010. Regulating alternative lifestyles in entomopathogenic bacteria. Curr. Biol. 20: 69-74.
118. Crawford, J.M. et al. 2012. Small molecule perimeter defense in entomopathogenic bacteria. Proc. Natl. Acad. Sci. U. S. A. 109: 10821-10826.
119. Joyce, S.A. et al. 2008. Bacterial biosynthesis of a multipotent stilbene. Angew. Chem. Int. Ed. Engl. 47: 1942-1945.
120. Hu, K. et al. 2006. A novel antimicrobial epoxide isolated from larval Galleria mellonella infected by the nematode symbiont, Photorhabdus luminescens (Enterobacteriaceae). Bioorg. Med. Chem. 14: 4677-4681.
121. Kontnik, R., J.M. Crawford & J. Clardy . 2010. Exploiting a global regulator for small molecule discovery in Photorhabdus luminescens. ACS Chem. Biol. 5: 659-665.
122. Sundar, L. & F.N. Chang . 1992. The role of guanosine-3', 5'-bis-pyrophosphate in mediating antimicrobial activity of the antibiotic 3, 5-dihydroxy-4-ethyl-trans-stilbene. Antimicrob. Agents Chemother. 36: 2645-2651.
123. Hu, K., J. Li & J.M. Webster . 1999. Nematicidal metabolites produced by Photorhabdus luminescens (Enterobacteriaceae), bacterial symbiont of entomopathogenic nematodes. Nematology 1: 457-469.
124. Buscató, E.L. et al. 2013. From a multipotent stilbene to soluble epoxide hydrolase inhibitors with antiproliferative properties. ChemMedChem 8: 919-923.
125. Kronenwerth, M. et al. 2014. Bioactive derivatives of isopropylstilbene from mutasynthesis and chemical synthesis. ChemBioChem 15: 2689-2691.
126. Fuchs, S.W. et al. 2013. Formation of 1, 3-cyclohexanediones and resorcinols catalyzed by a widely occurring ketosynthase. Angew. Chem. Int. Ed. Engl. 125: 4202-4206.
127. Brameyer, S. et al. 2015. Dialkylresorcinols as bacterial signaling molecules. Proc. Natl. Acad. Sci. U. S. A. 112: 572-577.
128. Harvey, A.L., R. Edrada-Ebel & R.J. Quinn . 2015. The re-emergence of natural products for drug discovery in the genomics era. Nat. Rev. Drug Discov. 14: 111-129.
129. Bouslimani, A. et al. 2014. Mass spectrometry of natural products: current, emerging and future technologies. Nat. Prod. Rep. 31: 718-12.
130. Weissman, K.J. 2015. The structural biology of biosynthetic megaenzymes. Nat. Chem. Biol. 11: 660-670.